乳腺癌患者远程医疗使用差异及其对临床试验入组的影响
该研究评估了2020年6月1日至2021年5月13日前瞻性随机试验开放入组期间就诊的乳腺癌患者,比较远程医疗与面对面初始咨询的使用差异及与临床试验入组的相关性。多因素分析显示年龄较大、失业、接受化疗及在本机构接受放疗与远程医疗使用减少相关;在符合入组条件的患者中,远程医疗与面对面就诊的临床试验入组无统计学显著差异。
要点
- 年龄较大、失业、接受化疗及在本机构接受放疗的患者较少使用远程医疗进行初始咨询。
- 远程医疗初始咨询者中10%符合试验入组条件,其中76%入组;面对面初始咨询者中14%符合条件,其中53%入组。
- 在符合入组条件的患者中,远程医疗与面对面就诊的临床试验入组无统计学显著差异。
核心结论
- 年龄较大、失业、接受化疗及后续在本机构接受放疗的患者较少使用远程医疗进行初始咨询,但符合入组条件的患者中远程医疗与面对面就诊的临床试验入组无统计学显著差异。
- 远程医疗可能是临床试验入组的有效平台,但改善其可及性的进一步策略至关重要。
研究设计与样本
- 评估2020年6月1日至2021年5月13日前瞻性随机试验开放入组期间就诊的乳腺癌患者。
- 采用单因素和多因素逻辑回归模型识别与虚拟(远程医疗)对比面对面初始咨询相关的因素,所有统计检验为双侧,P < .05 时拒绝原假设。
主要发现
- 共识别476例患者咨询,其中259例面对面就诊,217例远程医疗就诊。
- 多因素分析显示年龄增加、失业、接受化疗及在本机构接受放疗与远程医疗用于咨询就诊的使用减少相关。
- 217例远程医疗初始咨询患者中,10%符合试验入组条件,其中76%入组。
- 259例面对面初始咨询患者中,14%符合试验入组条件,其中53%入组。
- 在符合入组条件的患者中,远程医疗与面对面就诊的临床试验入组无统计学显著差异。
临床怎么用
- 作者认为远程医疗可能是临床试验入组的有效平台,但改善其可及性的进一步策略至关重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Since the COVID-19 pandemic, telemedicine has emerged as an alternative to office visits in routine radiation oncology practice. The purpose of this study was to identify factors associated with patient preference for an initial consult via telemedicine and correlation with clinical trial enrollment. METHODS AND MATERIALS: We evaluated patients with breast cancer seen during the open enrollment of a prospective randomized trial from June 1, 2020, to May 13, 2021. Univariate and multivariate logistic regression models were used to identify factors associated with virtual versus in-person initial consultation. All statistical tests were 2-sided, and the null hypothesis was rejected for P < .05. RESULTS: We identified 476 patient consultations with 259 office visits and 217 telemedicine visits. On multivariate analysis, increased age, unemployment, chemotherapy receipt, and radiation at our institution were associated with decreased usage of telemedicine for consultation visit. Out of 217 patients who underwent a telemedicine initial consultation, 10% were eligible to enroll on the trial, and of those eligible 76% enrolled. Out of 259 patients who underwent office visit initial consultation, 14% were eligible to enroll on the trial, and of those eligible 53% enrolled. Among eligible patients, there was no statistically significant difference in clinical trial enrollment between telemedicine and office visits. CONCLUSIONS: Older patients, unemployed patients, those receiving chemotherapy, and those who subsequently received radiation at our institution were less likely to use telemedicine for their initial consult. Despite these disparities in telemedicine usage, there was no difference in clinical trial enrollment. Telemedicine may be an effective platform for clinical trial enrollment though further strategies to improve its access are essential.
引用
- Hardy-Abeloos C, Karp J, Xiao J, et al. Disparities in the Uptake of Telemedicine and Implications for Clinical Trial Enrollment in Patients With Breast Cancer. Int J Radiat Oncol Biol Phys. 2022. PMID: 36273521. doi:10.1016/j.ijrobp.2022.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。